Prevalence and Factors Associated with Psychiatric Morbidity in Vitiligo Patients in India

Abstract

Vitiligo is a chronic dermatological disorder characterized by depigmented patches on the skin, which often results in profound psychosocial and emotional challenges for affected individuals. This abstract provides a comprehensive overview of a study conducted in India to investigate the prevalence and factors associated with psychiatric morbidity in patients with vitiligo. The study, conducted across multiple dermatology clinics in India, aimed to shed light on the often-overlooked psychological impact of vitiligo. Researchers employed standardized assessment tools, including the Patient Health Questionnaire (PHQ-9) and the Generalized Anxiety Disorder (GAD-7) scale, to evaluate the prevalence of depression and anxiety among vitiligo patients. Results revealed a higher-than-expected prevalence of psychiatric morbidity in this population, with a significant proportion of patients reporting symptoms of depression and anxiety. Factors such as the extent of vitiligo involvement, social stigma, and reduced quality of life were found to be strongly associated with the development of psychiatric comorbidities. This abstract underscores the importance of a holistic approach to the management of vitiligo, emphasizing not only dermatological interventions but also addressing the psychological well-being of patients. It highlights the need for dermatologists and mental health professionals to collaborate in providing comprehensive care, including psychoeducation, counseling, and support. In conclusion, this study serves as a valuable contribution to the understanding of the psychosocial impact of vitiligo in the Indian context. It underscores the urgency of recognizing and addressing the mental health needs of vitiligo patients to improve their overall quality of life and well-being.